期刊文献+

锌指蛋白139对人胃癌细胞株SGC7901增殖及凋亡调控机制探讨 被引量:1

Mechanism for transcription factor ZNF139's inhibition of proliferation and apoptosis regulation of gastric cancer cells
原文传递
导出
摘要 目的探讨抑制锌指蛋白139(zincfinger protein 139,ZNF139)对人胃癌细胞株SGC7901增殖和凋亡的影响及相关机制。方法构建针对ZNF139的siRNA重组质粒并导入SGC7901,逆转录-聚合酶链(RT-PCR)法检测抑制效率;MTT法测定siRNA-ZNF139组、阴性对照组和空白对照组SGC7901细胞活力;流式细胞术观察转染前后细胞周期及凋亡率变化;RT-PCR和蛋白质印迹法检测Cyclin D1、PCNA、Caspase-3和Bcl-2在各组中表达情况。结果0.8μg/mL siRNA-ZNF139质粒转染SGC7901细胞24、48和72h后细胞凋亡率分别为(4.823±0.685)%、(16.827±3.507)%和(20.107±3.305)%,差异有统计学意义,F=24.59,P=0.001 3。转染48h时空白对照组、阴性对照组和siRNA-ZNF139组G0/G1期细胞比例分别为(51.800±1.552)%、(52.633±0.361)%和(62.100±1.908)%,F=25.52,P=0.001 2;转染72h时G0/G1期细胞比例分别为(51.500±1.153)%、(53.567±1.582)%和(60.100±3.365)%,F=11.97,P=0.008。0.8μg/mL siRNA-ZNF139质粒转染SGC7901细胞48h后,siRNA-ZNF139组ZNF139、Cyclin D1、PCNA和Bcl-2mRNA表达分别为0.126±0.032、0.455±0.082、0.300±0.164和0.110±0.032,明显低于空白对照组的0.613±0.119、0.740±0.098、0.523±0.109和0.311±0.133,Caspase-3mRNA表达(0.230±0.028)明显高于空白对照组(0.089±0.018),P=0.001 9;siRNA-ZNF139组ZNF139、Cyclin D1、PCNA、Bcl-2蛋白表达分别为0.524±0.044 8、0.540±0.052 5、0.535±0.046 1和0.414±0.031,明显低于空白对照组的0.861±0.047、0.750±0.033、0.886±0.058和0.821±0.030,Caspase-3蛋白表达(1.004±0.105)明显高于空白对照组(0.517±0.027),P=0.002 1。结论 ZNF139可通过调节Cyclin D1、PCNA、Caspase-3和Bcl-2基因表达而影响胃癌细胞增殖、凋亡过程。 OBJECTIVE To explore the effect and mechanism of inhibiting ZNF139 to proliferationand apoptosis of human gastric cancer cell line SGC7901.METHODS siRNA recombinant plasmid targeting ZNF139 was structured and imported into SGC7901.ZNF139 inhibition rate was tested with RT-PCR.MTT method was applied to evaluate cell viability.Apoptosis rate and cell cycle were observed through FCM.Expressions of ZNF139,Cyclin D1,PCNA,Caspase-3and Bcl-2in different group of SGC7901 were tested by RT-PCR and Western blot.RESULTS 0.8μg/mL siRNA-ZNF139 was transfected into SGC7901 cell.After 24,48,72 h,Cell apoptosis rates were(4.823±0.685)%,(16.827±3.507)%,(20.107±3.305)% respectively,and difference was found among these groups(F=24.59,P=0.001 3).After 48 htransfection,ratios of G0/G1 phase of cells in blank group,negative group and siRNA-ZNF139 group were(51.800±1.552)%,(52.633±0.361)%,(62.100±1.908)% respectively(F=25.52,P=0.001 2).After 72 htransfection the ratios of G0/G1 phase of cells in 3groups were(51.500±1.153)%,(53.567±1.582)%,(60.100±3.365)% respectively(F=11.97,P=0.008).After 48 htransfection with 0.8μg/mL siRNA-ZNF139,relative expressions of ZNF139,Cyclin D1,PCNA,Bcl-2 mRNA in siRNA-ZNF139 group were 0.126±0.032,0.455±0.082,0.300±0.164,0.110±0.032 respectively,which were lower than that in blank group(0.613±0.119,0.740±0.098,0.523±0.109,0.311±0.133respectively),whereas expression of Caspase-3mRNA was higher in siRNA-ZNF139group(0.230±0.028)than that in blank group(0.089±0.018,P=0.001 9.Relative expressions of ZNF139,Cyclin D1,PCNA,Bcl-2proteins in siRNA-ZNF139 group were 0.524±0.044 8,0.540±0.052 5,0.535±0.046 1,0.414±0.031 respectively,which were lower than that in blank group(0.861±0.047,0.750±0.033,0.886±0.058,0.821±0.030),whereas expression of Caspase-3protein was higher in siRNA-ZNF139group(1.004±0.105)than that in blank group(0.517±0.027,P=0.002 1).CONCLUSION ZNF139 may influence the proliferation and apoptosis regulation of gastric cancer cells by regulating Cyclin D1,PCNA,Caspase-3and Bcl-2genes.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第9期655-660,共6页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(81072033 81372580) 河北省自然科学基金(C2010000619) 河北省普通高校强势特色学科资助项目(冀教高[2005]52) 河北省科技支撑项目(14277779D) 河北省卫生和计划生育委员会重大医学科研课题(zd2013040)
关键词 锌指蛋白139 胃癌 RNA干扰 增殖 凋亡 zinc finger protein 139 gastric cancer RNA interference proliferation apoptosis
  • 相关文献

参考文献8

二级参考文献40

共引文献45

同被引文献19

  • 1Martinez de Pinillos Bayona A, Moore CM, Loizidou M, et al. Enhancing the efficacy of cytotoxic agents for cancer therapy u- sing photochemical internalisation[J].Int J Cancer, 2016, 138 (5):1049-1057.
  • 2Chen T, Sun Y, Ji P, et al. Topoisornerase 11 a in chromosome instability and personalized cancer therapy[J]. Oncogene,2015, 34(31) :4019-4031.
  • 3Ji YY, Zhu YM, Wang JW. GS-2, a pyrazoloE1,5-a~indole de- rivative with inhibitory activity of topoisomerases, exerts its po- tent cytotoxic activity by ROS generation[J].Environ Toxicol Pharmacol, 2013, 36(3) :1186-1196.
  • 4Katayama H, Kiryu Y, K aneko K, et al. Anti-cance ractivilies o{ pyrazo[oE1, 5 a~ indole derivatives[J].Chem Pharm Bull, 2000, 48(ll): 1628 1633.
  • 5Umemura K, Mizushima T, Katayama H, et al. Inhibition of DNA topoisomerases 1I and/or ][ by pyrazolo[1, 5 a~indole de- rivatives and their growth inhibitory activities [J]. Mol Pharma col, 2002, 62(4):873-880.
  • 6Chi JW, Hang CC, Zhu YM, et al. Synthesis of indoloE1,2 b- indazole derivatives via copper( I )-catalyzed intramolecular ami- nation reaction[J]. Synthetic Commun, 2010, 40(8): 1123 1137;.
  • 7Peixoto P, Bailly C, David Cordonnier MH. Topoisomerase I mediated DNA relaxation as a tool to study intercalation o{ sma molecules into supercoiled DNA[J]. Methods Mol Biol, 2010 613,235-256.
  • 8Liu Y, Gao F, Jiang H, el al. Induction of DNA damage and ATF3 by retigeric acid B, a novel topoisomerase 1I inhibitor, promotesapoptosis in prostate cancer cells [J]. Cancer Lett, 2013, 337(1):66 -76.
  • 9Shen Y, Chen W, Zhao B et al. CS is a novel topoisomerase 1I inhibitor with favorable drug resistance profiles[J]. Biochem Biophys Res Commun, 2014, 453(3) :302-308.
  • 10Tian C, Ding P, Yuan Z, et al. A novel dual EGFR/HER2 inhibitor KU004 induces cell cycle arrest and apoptosis in HER2 overexpressing cancer cells[J]. Apoptosis, 2015.[Epub ahead of print].

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部